Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinidazole for Bacterial Vaginosis
NCT00229216Phase 3Completed
- Sponsor
- Mission Pharmacal Company
- Start
- Jan 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tinidazole in bacterial vaginosis (BV), sponsored by Mission Pharmacal Company. Started Jan 2005; status: completed.
02
Drugs
tinidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00229216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229216.